| Bioactivity | Riamilovir is an antiviral drug whose activity is primarily directed against RNA viruses. Riamilovir acts directly on the virus's RNA-dependent RNA polymerase, thereby preventing the virus from replicating. This mechanism allows Riamilovir to effectively reduce the amount of virus, accelerate the relief of symptoms, and help reduce the severity of the disease. Riamilovir can be used in the study of acute respiratory viral infections caused by new variants of SARS-CoV-2[1]. |
| CAS | 123606-06-4 |
| Formula | C5H4N6O3S |
| Molar Mass | 228.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Сабитов А У, et al. Практический опыт применения препарата Риамиловир в лечении пациентов с COVID-19 средней степени тяжести[J]. Антибиотики и химиотерапия, 2020, 65(7-8): 27-30. |
Riamilovir
CAS: 123606-06-4 F: C5H4N6O3S W: 228.19
Riamilovir is an antiviral drug whose activity is primarily directed against RNA viruses. Riamilovir acts directly on th
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.